Researchers from the Center for Regenerative Medicine (CReM) have assembled the largest repository of patient derived stem cells (iPSCs) from patients with alpha-1 antitrypsin deficiency (AATD). “Our goal is to get these cells out to other researchers so that they will use them to ultimately help patients with AATD. ToContinue Reading